These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7071319)

  • 21. Electrocoagulation and the risk of cervical neoplasia.
    La Vecchia C; Franceschi S; Decarli A; Fasoli M; Gentile A; Gritti P
    Obstet Gynecol; 1985 Nov; 66(5):703-7. PubMed ID: 4058829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of a colpocytologic mass screening and in-patient casework: comparison by age groups.
    Canevini P; Spinelli M; Fibbi L
    Tumori; 1977; 63(6):575-84. PubMed ID: 601885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cancer of the cervix, papillomavirus, contraception and tobacco].
    Thiry L; Vokaer R; Detremmerie O; De Schepper N; Herzog A; Bollen A
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):477-86. PubMed ID: 8228010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gynaecological cytology screening in South Australia: a 23-year experience.
    MacCormac L; Lew W; King G; Allen PW
    Med J Aust; 1988 Nov; 149(10):530-6. PubMed ID: 3185322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of preclinical lesions of the cervix uteri].
    Dabancens A
    Rev Med Chil; 1986 Jun; 114(6):586-90. PubMed ID: 3575955
    [No Abstract]   [Full Text] [Related]  

  • 26. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri.
    Harris RW; Brinton LA; Cowdell RH; Skegg DC; Smith PG; Vessey MP; Doll R
    Br J Cancer; 1980 Sep; 42(3):359-69. PubMed ID: 7426342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population.
    Sadeghi SB; Sadeghi A; Robboy SJ
    Cancer; 1988 Jun; 61(11):2359-61. PubMed ID: 3365664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in abnormal cervical cytology.
    Heyerdahl-O'Dowd TD
    Ir Med J; 1982 Nov; 75(11):419-22. PubMed ID: 7174261
    [No Abstract]   [Full Text] [Related]  

  • 29. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
    van Oortmarssen GJ; Habbema JD
    Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk for cervical disease in HIV-infected women--New York City.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Nov; 39(47):846-9. PubMed ID: 2172758
    [No Abstract]   [Full Text] [Related]  

  • 31. [The incidence of positive cervix cytology 1980-1989].
    Gitsch G; Kainz C; Breitenecker G
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():221. PubMed ID: 8118280
    [No Abstract]   [Full Text] [Related]  

  • 32. The significance of human papilloma virus atypia ('wart virus infection') found alone on cervical cytology screening.
    Pagano R; Chanen W; Rome RM; Johnstone NR
    Aust N Z J Obstet Gynaecol; 1987 May; 27(2):136-9. PubMed ID: 2823784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical intraepithelial neoplasia in younger women.
    Cecchini S
    Lancet; 1982 Oct; 2(8304):926-7. PubMed ID: 6126766
    [No Abstract]   [Full Text] [Related]  

  • 34. Cervical cytology screening in two Yorkshire areas: pattern of service.
    Parkin DM; Collins W; Clayden AD
    Public Health; 1981 Nov; 95(6):311-21. PubMed ID: 7335843
    [No Abstract]   [Full Text] [Related]  

  • 35. Cervical cancer screening in an urban emergency department.
    Hogness CG; Engelstad LP; Linck LM; Schorr KA
    Ann Emerg Med; 1992 Aug; 21(8):933-9. PubMed ID: 1497160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical squamous cells of undetermined significance: community incidence and management review.
    Delmore J; Williams CM; Nielsen ML; Kluzak T; Horbelt DV; Stembridge TW; Christman CM
    Kans Med; 1995; 96(3):133-4. PubMed ID: 8583740
    [No Abstract]   [Full Text] [Related]  

  • 37. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 38. Cervical cytology in Zambia.
    Grech ES; O'Dowd MJ; Tsirkina GA; Zeigler O
    Med J Zambia; 1977; 11(4):112-7. PubMed ID: 919781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An attempt to estimate the incidence of cervical dysplasia in a group of New Zealand women using contraception. The New Zealand Contraception and Health Study Group.
    Epidemiology; 1995 Mar; 6(2):121-6. PubMed ID: 7742396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mode ages of women with cervical dysplasia.
    Carson HJ; DeMay RM
    Obstet Gynecol; 1993 Sep; 82(3):430-4. PubMed ID: 8355947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.